Novartis ends Wet AMD trial for Beovu citing safety concerns
For this year the company, based in Basel revenue will be around 51.97 billion CHF. This is according to the average of the analysts' estimates. This is slightly more than 2020's revenue of 49.9 billion CHF.
Historical revenues and results Novartis plus estimates 2020
The analysts expect for 2021 a net profit of 14.18 billion CHF. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 6.31 CHF. Based on this the price/earnings-ratio is 12.84.
Huge dividend Novartis
For this year the analysts expect a dividend of 3.31 CHF per share. The dividend yield is then 4.09 percent. The average dividend yield of the pharmaceutical companies equals a limited 1.39 percent.Most recent target prices around 96 CHF
Jefferies & Co., UBS and Oddo BHF recently provided recommendations for the stock.Based on the current number of outstanding shares Novartis 's market capitalization 183.51 billion CHF. The Novartis stock was the past 12 months quite volatile. Since last June the stock is 1 percent higher. This year the stock price moved between 70 and 87 CHF.
Historical stock prices Novartis from 2007 till 2021
On Friday the stock closed at 81.02 CHF.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
